New project aims to increase the EU’s ability to combat flavivirus threats

A new project – FLAVIVACCINE – aims to increase the EU’s ability to combat epidemic and pandemic viral threats both in Europe and around the world.

Cosmo and Hyundai Pharm Announce Signing of License Agreement for Winlevi® in Korea – Biotech Investments

Cosmo Pharmaceuticals N.V. / Key word(s): Agreement Cosmo and Hyundai Pharm Announce Signing of License Agreement for Winlevi® in Korea 22.06.2023 / 06:15 GMT/BST Dublin,

June 23, 2023

Getinge inks $320M Healthmark takeover to bolster US sterile reprocessing capabilities

Dive Brief: Getinge has paid $320 million to acquire Healthmark Industries for its U.S. sterile reprocessing capabilities. Healthmark makes instrument care and infection control consumables

October 12, 2023

More than 1,000 small changes in DNA identified that influence age of first period

Researchers examined nearly 800,000 women’s DNA to explore puberty timing complexities. They identified signals related to menarche timing and investigated their influence on puberty onset.

July 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.